
Please try another search
(Reuters) -Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee.
The San Diego-headquartered company, valued at $31.6 billion, had long planned to increase the size of the board to 11 by adding directors with experience as a healthcare CEO and as a chief financial officer (CFO) with Wall Street expertise.
On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic (NASDAQ:HOLX) Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp (NYSE:EW), as new directors. MacMillan was also elected as non-executive chairman.
Wall Street analysts welcomed the move, with analysts at Evercore ISI writing: "Steve and Scott are well known and respected by Wall Street and should bring a ton of confidence into the (Illumina (NASDAQ:ILMN)) story."
Illumina's stock price, which has fallen nearly 20% in the last 52 weeks, traded modestly higher in a broader market that was also up.
The news comes one week after a boardroom battle between the company and billionaire investor Icahn ended in a vote that both sides hailed as a victory. It was the biggest fight in corporate America to be voted on by shareholders this year.
Shareholders elected one of Icahn's three nominees, Andrew Teno, to the board after criticizing the company for its $7.1 billion acquisition of cancer test maker Grail and saying former CEO Jay Flatley should return and run the company.
Teno knocked out board chairman John Thompson in the vote.
Illumina CEO Francis deSouza, who was challenged by Icahn nominee Vincent Intrieri, survived the campaign and won more votes than all Icahn nominees to retain his position. But he also got the fewest number of votes of candidates elected from the Illumina side.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.